2021 Vitiligo International Symposium (VIS)

All times listed below are central time – USA (Chicago, IL). To find the event time in your local time, click here.

December 4, 2021
  • December 4, 2021 5:00 AM CT
    Virtual Poster Session

    Go online, before and after the meeting or anytime to review the submitted academic posters.

    Click --> Review the iPosters from November 26, 2021 - January 31, 2022.

  • December 4, 2021 06:30 AM CT
    Welcome Message

    The Global Vitiligo Foundation president and the meeting chairs will welcome everyone to the symposium. A brief update about the GVF will be given.

  • December 4, 2021 06:40 AM CT
    Invited Speaker # 1 - Thierry Passeron, MD, PhD

    Oral Gliadin-Protected Superoxide Dismutase in Addition to Phototherapy for Treating Non-segmental Vitiligo: A 24-Week Prospective Randomized Placebo-Controlled Study

    The use of GP-SOD combined with NB-UVB could be a useful add-on in the treatment of vitiligo patients with excellent tolerability and safety.

  • December 4, 2021 7:00 AM CT
    Abstract #1 - Hyun Jeong Ju, MD

    Progressive and Extensive Hypomelanosis of Childhood: A Novel Disease Entity Distinguished from Other Hypomelanotic Disorders

  • December 4, 2021 7:10 AM CT
    Abstract #2 - Marcella Willemsen, MSc

    Immunophenotypic Analysis Reveals Differences in Circulating Immune Cells in Peripheral Blood of Segmental and Non-segmental Vitiligo Patients

  • December 4, 2021 7:20 AM CT
    Abstract #3 - Nanja van Geel, MD, PhD & Jolien Duponselle, MD

    Image Analyses Systems to Calculate the Surface Area of Vitiligo Lesions: A Systematic Review of Measurement Properties

  • December 4, 2021 7:30 AM CT
    Invited Speaker #2 - Caroline Lapoole, PhD

    Modeling Microbial Impact on Autoimmune Depigmentation in Mice

  • December 4, 2021 7:50 AM CT
    Abstract #4 - Saurabh Bhatia, MD

    Efficacy of NB-UVB in Progressive Versus Non-progressive Non-segmental Vitiligo: A Prospective Comparative Study

  • December 4, 2021 8:00 AM CT
    Abstract #5 - Khaled Ezzedine, MD, PhD

    Efficacy and Safety of the Oral Janus Kinase 3/Tec Inhibitor Ritlecitinib (PF-06651600) In Adults With Active Non-segmental Vitiligo: Results From a Phase 2b, Randomized, Dose-Ranging Study With an Extension Period

  • December 4, 2021 8:10 AM CT
    Demo and Data Share - MyVitiligoTeam
  • December 4, 2021 8:20 AM CT
    Poster Q&A #1

    Click here to see the virtual posters


    Shiwangi Rana, MD
    Anthropometric and Biochemical Evaluation for Assessing Risk of Metabolic Syndrome in Childhood Vitiligo: A Case Control Study

    Alpana Mohta, MD
    The Correlation of Extent, Distribution and Symptomatology of Vitiligo Patients With the Impairment in Quality-Of-Life

    Ju Hee Han, MD
    Risk of Vitiligo After Transplantation

    Fabiana Castro Porto Silva Lopes, MD
    Insurance Coverage for Phototherapy for Vitiligo in Comparison to Psoriasis and Atopic Dermatitis

  • December 4, 2021 8:40 AM CT
    Invited Speaker #3 - Mauro Picardo, MD

    Vitiligo: A Diverse Perspective

  • December 4, 2021 9:00 AM CT
    Abstract #6 - Nicoline Post, MD

    Meek Micrografting: A Novel Surgical Technique for the Treatment of Depigmentation

  • December 4, 2021 9:10 AM CT
    Abstract #7 - Helen Kitchen, MSc

    A Qualitative Study to Explore the Content Validity of the Vitiligo Patient Priority Outcome (ViPPO) Measures

  • December 4, 2021 9:20 AM CT
    Abstract #8 - Camille Robinson, BS

    Assessment of Vitiligo Patients’ Perceptions and Opinions About Their Dermatologists When They Were First Diagnosed

  • December 4, 2021 9:30 AM CT
    Invited Speaker #4 - Marcella Willemsen, MSc

    Impaired Ifn-γ-Induced PD-L1 Expression on Human Vitiligo Melanocytes

  • December 4, 2021 9:50 AM CT
    Poster Q&A #2

    Click here to see the virtual posters


    Lamia Elgarhy, MD
    Transdermal Delivery of 5-Fluorouracil by Fractional CO2 Laser Versus Intralesional Injection of 5-Fluorouracil, Both Followed by Narrow Band UVB in Treatment of Stable Vitiligo

    Yvon Gauthier, BSA
    Varicella-Zoster Virus (VZV) In Recent Segmental Vitiligo Skin : Pathological, Immunochemical and Ultrastructural Findings ( A Preliminary Study)

    Jalal Maghfour, Mpharm, PGDipCPP, PGDipPTQA
    To Evaluate the Comparative Efficacy Between Visible Light Combined With UVA1 and Narrow Band Uv Light for the Treatment of Repigmentation in Generalized Vitiligo Patients

    Nicole Syder, MD
    Vitiligo and Makeup: Analyzing Interest and Usage Trends in the 21st Century

  • December 4, 2021 10:20 AM CT
    Wrap up and Summary of the Day

    Join the chairs as the highlight some of the top topics of the day.

  • December 4, 2021 10:20 AM CT
    Virtual Poster Session

    Go online, before and after the meeting or anytime to review the submitted academic posters.

    Click --> Review the iPosters from December 2, 2021 - January 31, 2022.

December 5, 2021
Event Details
  • Start Date
    December 4, 2021 6:30 am
  • End Date
    December 5, 2021 10:30 am
  • Status